Clinical Trials with Vitamin E in Cardiovascular Disease: Are they Meaningful?

Thromb Haemost 2001; 86(04): 1121-1122
DOI: 10.1055/s-0037-1616546

Letters to the Editor

Schattauer GmbH

Authors

Francesco Violi

¹Istituto di I Clinica Medica, University La Sapienza, Rome, Italy
Fausta Micheletta

¹Istituto di I Clinica Medica, University La Sapienza, Rome, Italy
Luigi Iuliano

¹Istituto di I Clinica Medica, University La Sapienza, Rome, Italy

References
1 Violi F, Micheletta F, Iuliano L. Vitamin E Atherosclerosis and Thrombosis. Thromb Haemost 2001; 85: 766-70.
2 Marchioli R. Vitamin E and cardiovascular disease. Thromb Haemost 2001; 85: 758-60.
3 Rapola JM, Virtamo J, Ripatti S, Huttunen JK, Albanes D, taylor PR, Heinonen OP. Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet 1997; 349: 1715-20.
4 Stephens NG, Parsons A, Schofield PM, Kelly F, Cheesman K, Mitchinson MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study. Lancet 1996; 347: 781-6.
5 Traber MG, Jialal I. Measurement of lipid-soluble vitamins: further adjustment needed?. Lancet 2000; 355: 2013-4.
6 Violi F, Micheletta F, Iuliano L. Antioxidant strategy for cardiovascular disease. Lancet 2001; 357: 1706.
7 Boaz M, Smetana S, Weinstein T, Gafter U, Iaina A, Knecht A, Weissgarten Y, Brunner D, Fainaru M, Green MS. Secondary prevention with anti-oxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet 2000; 356: 1213-18.
8 Boaz M, Smetana S, Green MS. Vitamin E supplementation. Lancet 2001; 357: 632-3.